UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors

NCT05848999 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Mesothelin-positive Advanced Malignant Solid Tumors

Interventions

BIOLOGICAL: UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)

Sponsor

Zhejiang University

Collaborators

[object Object]